ID

18979

Description

Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00126230

Lien

https://clinicaltrials.gov/show/NCT00126230

Mots-clés

Versions (1)
  1. 28/11/2016 28/11/2016 -
Téléchargé le

28 novembre 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT00126230

Anglais

Eligibility Prostate Cancer NCT00126230

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients older than 18 years and less than 80 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
histologically-proven adenocarcinoma of the prostate
Description

Adenocarcinoma of prostate

Type de données

boolean

Alias
UMLS CUI [1]
C0007112
evidence of bone metastases and progressive, hormone-refractory, disease
Description

Secondary malignant neoplasm of bone Evidence | Progressive Disease Hormones refractory

Type de données

boolean

Alias
UMLS CUI [1,1]
C0153690
UMLS CUI [1,2]
C0332120
UMLS CUI [2,1]
C1335499
UMLS CUI [2,2]
C0019932
UMLS CUI [2,3]
C0205269
no previous chemotherapy
Description

Chemotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C0392920
no previous radiotherapy, except radiotherapy directed to the prostate and/or to a single bony lesion
Description

Therapeutic radiology procedure | Radiotherapy to prostate | Therapeutic radiology procedure Bone lesion Single

Type de données

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2]
C0948317
UMLS CUI [3,1]
C1522449
UMLS CUI [3,2]
C0238792
UMLS CUI [3,3]
C0205171
no previous carcinoma, except basal-cell carcinoma of the skin
Description

Carcinoma | Basal cell carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0007097
UMLS CUI [2]
C0007117
adequate renal function: measured or calculated creatinine clearance > 60 ml/min
Description

Renal function | Creatinine clearance measurement | Estimation of creatinine clearance by Cockcroft-Gault formula

Type de données

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0373595
UMLS CUI [3]
C2711451
absolute granulocyte count ≥ 1,500/mm3, platelets ≥ 100,000 mm3, bilirubin ≤ 1.5 fold the upper normal value
Description

Absolute neutrophil count | Platelet Count measurement | Serum total bilirubin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
UMLS CUI [3]
C1278039
signed informed consent.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients infected by the human immunodeficiency virus (hiv)
Description

HIV Infections

Type de données

boolean

Alias
UMLS CUI [1]
C0019693
patients who do not fit inclusion criteria
Description

Inclusion criteria Mismatch

Type de données

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C1881865
Retour au début de la page

Similar models

Eligibility Prostate Cancer NCT00126230

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
patients older than 18 years and less than 80 years
boolean
C0001779 (UMLS CUI [1])
Adenocarcinoma of prostate
Item
histologically-proven adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
Secondary malignant neoplasm of bone Evidence | Progressive Disease Hormones refractory
Item
evidence of bone metastases and progressive, hormone-refractory, disease
boolean
C0153690 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C1335499 (UMLS CUI [2,1])
C0019932 (UMLS CUI [2,2])
C0205269 (UMLS CUI [2,3])
Chemotherapy
Item
no previous chemotherapy
boolean
C0392920 (UMLS CUI [1])
Therapeutic radiology procedure | Radiotherapy to prostate | Therapeutic radiology procedure Bone lesion Single
Item
no previous radiotherapy, except radiotherapy directed to the prostate and/or to a single bony lesion
boolean
C1522449 (UMLS CUI [1])
C0948317 (UMLS CUI [2])
C1522449 (UMLS CUI [3,1])
C0238792 (UMLS CUI [3,2])
C0205171 (UMLS CUI [3,3])
Carcinoma | Basal cell carcinoma
Item
no previous carcinoma, except basal-cell carcinoma of the skin
boolean
C0007097 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
Renal function | Creatinine clearance measurement | Estimation of creatinine clearance by Cockcroft-Gault formula
Item
adequate renal function: measured or calculated creatinine clearance > 60 ml/min
boolean
C0232804 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
C2711451 (UMLS CUI [3])
Absolute neutrophil count | Platelet Count measurement | Serum total bilirubin measurement
Item
absolute granulocyte count ≥ 1,500/mm3, platelets ≥ 100,000 mm3, bilirubin ≤ 1.5 fold the upper normal value
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
Informed Consent
Item
signed informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
HIV Infections
Item
patients infected by the human immunodeficiency virus (hiv)
boolean
C0019693 (UMLS CUI [1])
Inclusion criteria Mismatch
Item
patients who do not fit inclusion criteria
boolean
C1512693 (UMLS CUI [1,1])
C1881865 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial